At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Co-designed cardiovascular brief intervention (behavioural)
- How long the study runs
- Study runs about 19 months (dates as stated)
- About the drug or intervention
- Co-designed cardiovascular brief intervention — behavioural: Patients will be randomised to a brief intervention where they will be informed of their high-sensitivity cardiac troponin value and cardiovascular risk.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 118
- Started
- 2025-08-25
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for cardiovascular diseases
- • NA - 118 participants
- • Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with cardiovascular diseases
Where?
- • Edinburgh - NHS Lothian
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future. The investigators know this by taking a blood test (troponin) which looks at damage to the patient's heart. These patients are often sent home from hospital with no information about their risk of heart disease. A patient survey revealed that patients in the emergency department would like to receive more information about heart disease. In this study the investigators will provide patients who are at increased risk of cardiovascular disease with their troponin value. The investigators will deliver this information within a cardiovascular brief intervention, which is a short conversation with a patient about their health. In a previous study the investigators carried out some interviews with patients to find out how their results should be delivered and what information should be included in a cardiovascular brief intervention. The investigators also asked them the best way to provide patients with this information. The aim of this part of the study it to determine if the new cardiovascular brief intervention helps patients understand their risk and if it results in them making changes to their health.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
Biomarkers mentioned
What the study is looking for
- ✓Patients who present to the Emergency Department with symptoms suggestive of acute coronary syndrome
- ✓A maximum high-sensitivity heart troponin I between 5 ng/L and the sex-specific 99th centile.
- ✓Resides in Scotland and has a CHI number
- ✓Adults aged 18 and over
- ✓No history of cardiovascular disease
Who cannot take part
- ✗Patients with a diagnosis of acute coronary syndrome during index presentation
- ✗Patients who are not able to give agreement to take part
- ✗Patients who do not speak English
- ✗Patients who are unable to attend hospital as outpatient to receive the cardiovascular brief intervention
- ✗Patients with ongoing or planned cardiovascular investigations or interventions
See the full criteria
Where Is This Study? (1 UK site)
NHS Lothian
Edinburgh, United Kingdom